30-Sep-2026
No headlines found.
Chipmakers Now Ship Protein-Folding AI as Plug-and-Play Microservices
Globe Newswire (Tue, 22-Sep 8:30 AM ET)
Business Wire (Mon, 21-Sep 8:46 AM ET)
MindWalk Reports 21% Revenue Growth and Gross Margin Expansion to 59% in Fiscal First Quarter 2027
Business Wire (Mon, 14-Sep 4:56 PM ET)
Business Wire (Mon, 14-Sep 8:46 AM ET)
MindWalk to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Business Wire (Thu, 10-Sep 8:34 AM ET)
Business Wire (Tue, 8-Sep 8:30 AM ET)
The Market Just Told You Which Layer Of AI Biology It Is Paying For
Globe Newswire (Thu, 3-Sep 2:10 PM ET)
Globe Newswire (Wed, 19-Aug 8:56 AM ET)
AI Found an Influenza Target That Survives Viral Mutation
Globe Newswire (Mon, 10-Aug 9:10 AM ET)
MindWalk Showcases ReefIQ for AI Drug Discovery at AMD Advancing AI
Business Wire (Thu, 23-Jul 4:02 PM ET)
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
Mindwalk Holdings Corp. trades on the NASDAQ stock market under the symbol HYFT.
As of September 30, 2026, HYFT stock price declined to $1.33 with 96,779 million shares trading.
HYFT has a beta of 1.72, meaning it tends to be more sensitive to market movements. HYFT has a correlation of 0.06 to the broad based SPY ETF.
HYFT has a market cap of $62.42 million. This is considered a Micro Cap stock.
Last quarter Mindwalk Holdings Corp. reported $3 million in Revenue and -$.09 earnings per share. This fell short of revenue expectation by $-480,476 and missed earnings estimates by -$.04.
The top ETF exchange traded funds that HYFT belongs to (by Net Assets): IWC.
HYFT has underperformed the market in the last year with a return of -23.4%, while the SPY ETF gained +16.1%. In the last 3 month period, HYFT fell short of the market, returning -20.2%, while SPY returned +3.2%. However, in the most recent 2 weeks HYFT has outperformed the stock market by returning +14.7%, while SPY returned +0.9%.
HYFT support price is $1.31 and resistance is $1.45 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HYFT shares will trade within this expected range on the day.